117 related articles for article (PubMed ID: 23508885)
1. Non-steroidal anti-inflammatory drugs and venous thromboembolism in women.
Bergendal A; Adami J; Bahmanyar S; Hedenmalm K; Lärfars G; Persson I; Sundström A; Kieler H
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):658-66. PubMed ID: 23508885
[TBL] [Abstract][Full Text] [Related]
2. Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study.
Lee T; Lu N; Felson DT; Choi HK; Dalal DS; Zhang Y; Dubreuil M
Rheumatology (Oxford); 2016 Jun; 55(6):1099-105. PubMed ID: 26983451
[TBL] [Abstract][Full Text] [Related]
3. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism.
Schmidt M; Christiansen CF; Horváth-Puhó E; Glynn RJ; Rothman KJ; Sørensen HT
J Thromb Haemost; 2011 Jul; 9(7):1326-33. PubMed ID: 21592304
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for venous thromboembolism in pre-and postmenopausal women.
Bergendal A; Bremme K; Hedenmalm K; Lärfars G; Odeberg J; Persson I; Sundström A; Kieler H
Thromb Res; 2012 Oct; 130(4):596-601. PubMed ID: 22704078
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD.
Ishiguro C; Wang X; Li L; Jick S
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1168-75. PubMed ID: 25195779
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism does not share strong familial susceptibility with pre-eclampsia/eclampsia: a nationwide family study in Sweden.
Zöller B; Li X; Sundquist J; Sundquist K
BJOG; 2013 Sep; 120(10):1200-6. PubMed ID: 23906308
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.
Schmidt M; Christiansen CF; Mehnert F; Rothman KJ; Sørensen HT
BMJ; 2011 Jul; 343():d3450. PubMed ID: 21727167
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis.
Ungprasert P; Srivali N; Wijarnpreecha K; Charoenpong P; Knight EL
Rheumatology (Oxford); 2015 Apr; 54(4):736-42. PubMed ID: 25252703
[TBL] [Abstract][Full Text] [Related]
10. Self-reported family history in estimating the risk of hormone, surgery and cast related VTE in women.
Sonnevi K; Bergendal A; Adami J; Lärfars G; Kieler H
Thromb Res; 2013 Aug; 132(2):164-9. PubMed ID: 23800637
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study.
Meaidi A; Mascolo A; Sessa M; Toft-Petersen AP; Skals R; Gerds TA; Wessel Skovlund C; Morch LS; Rossi F; Capuano A; Lidegaard O; Torp-Pedersen C
BMJ; 2023 Sep; 382():e074450. PubMed ID: 37673431
[TBL] [Abstract][Full Text] [Related]
12. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
13. Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs.
Castellsague J; Holick CN; Hoffman CC; Gimeno V; Stang MR; Perez-Gutthann S
Pharmacotherapy; 2009 Dec; 29(12):1397-407. PubMed ID: 19947799
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of venous thromboembolism within the first year after Staphylococcus aureus bacteraemia: a nationwide observational matched cohort study.
Mejer N; Westh H; Schønheyder HC; Jensen AG; Larsen AR; Skov R; Benfield T;
J Intern Med; 2014 Apr; 275(4):387-97. PubMed ID: 24118528
[TBL] [Abstract][Full Text] [Related]
15. Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden.
Zöller B; Li X; Sundquist J; Sundquist K
Circulation; 2011 Aug; 124(9):1012-20. PubMed ID: 21824919
[TBL] [Abstract][Full Text] [Related]
16. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database.
Sundström A; Seaman H; Kieler H; Alfredsson L
BJOG; 2009 Jan; 116(1):91-7. PubMed ID: 19016686
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism does not share strong familial susceptibility with coronary heart disease: a nationwide family study in Sweden.
Zöller B; Li X; Sundquist J; Sundquist K
Eur Heart J; 2011 Nov; 32(22):2800-5. PubMed ID: 21750095
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
Sveinsdottir SV; Saemundsson Y; Isma N; Gottsäter A; Svensson PJ
Thromb Res; 2012 Sep; 130(3):467-71. PubMed ID: 22512897
[TBL] [Abstract][Full Text] [Related]
19. Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism.
Biere-Rafi S; Di Nisio M; Gerdes V; Porreca E; Souverein P; Boer A; Büller H; Kamphuisen P
Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):635-42. PubMed ID: 21462279
[TBL] [Abstract][Full Text] [Related]
20. Incidence of venous thromboembolism following initiation of non-steroidal anti-inflammatory drugs in U.S. women.
Kinsey TL; Stürmer T; Funk MJ; Poole C; Simpson RJ; Glynn RJ
Rheumatology (Oxford); 2020 Sep; 59(9):2502-2511. PubMed ID: 31990357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
